Generex Biotechnology Corp (GNBT) - Strategic SWOT Analysis Review

December 2019 | 38 pages | ID: G32B3931F487EN
GlobalData

Abstracts

Generex Biotechnology Corp (GNBT) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  
  Highlights
  
  Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using proprietary RapidMist device. Generex through its subsidiary, Antigen Express, has expanded its focus to include immunomedicines incorporating proprietary vaccine formulations for the treatment of infectious, malignant, allergic, and autoimmune diseases. Generex is headquartered in Miramar, Florida, the US.
  
  Generex Biotechnology Corp Key Recent Developments
  
  Dec 11,2019: Generex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of Directors
  Sep 27,2019: Generex Biotechnology announces plans to establish the NuGenerex Diabetes Research Center in collaboration with Arizona Endocrinology Group & Paradise Valley Medical Family Medicine
  Sep 12,2019: Generex Biotechnology announces webcast and invites all shareholders to see and listen to the corporate presentation from the 21st Annual H.C. Wainwright Global Healthcare Investment Conference
  Sep 10,2019: Generex Biotechnology Signs Letters of Intent to establish NuGenerex Health MSO with Arizona Endocrinology Center & Paradise Valley Family Medicine
  Aug 01,2019: Generex Biotechnology welcomes MediSource Partners to the NuGenerex Family of Companies
  
  Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
  Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Generex Biotechnology Corp - Key Facts
Generex Biotechnology Corp - Key Employees
Generex Biotechnology Corp - Key Employee Biographies
Generex Biotechnology Corp - Major Products and Services
Generex Biotechnology Corp - History
Generex Biotechnology Corp - Company Statement
Generex Biotechnology Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Generex Biotechnology Corp - Business Description
Generex Biotechnology Corp - SWOT Analysis
SWOT Analysis - Overview
Generex Biotechnology Corp - Strengths
Generex Biotechnology Corp - Weaknesses
Generex Biotechnology Corp - Opportunities
Generex Biotechnology Corp - Threats
Generex Biotechnology Corp - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Generex Biotechnology Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Dec 11, 2019: Generex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of Directors
Sep 27, 2019: Generex Biotechnology announces plans to establish the NuGenerex Diabetes Research Center in collaboration with Arizona Endocrinology Group & Paradise Valley Medical Family Medicine
Sep 12, 2019: Generex Biotechnology announces webcast and invites all shareholders to see and listen to the corporate presentation from the 21st Annual H.C. Wainwright Global Healthcare Investment Conference
Sep 10, 2019: Generex Biotechnology Signs Letters of Intent to establish NuGenerex Health MSO with Arizona Endocrinology Center & Paradise Valley Family Medicine
Aug 01, 2019: Generex Biotechnology welcomes MediSource Partners to the NuGenerex Family of Companies
Jul 31, 2019: Generex Biotechnology introduces Pantheon Medical, the newest member of the NuGenerex family of Companies
Jul 12, 2019: Generex Biotechnology acquires Pantheon Medical
Jul 10, 2019: Generex Biotechnology provides fiscal year overview
Jun 03, 2019: Generex Biotechnology announces date for rescheduled May 15th Investor Conference Call
Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Generex Biotechnology Corp, Key Facts
Generex Biotechnology Corp, Key Employees
Generex Biotechnology Corp, Key Employee Biographies
Generex Biotechnology Corp, Major Products and Services
Generex Biotechnology Corp, History
Generex Biotechnology Corp, Subsidiaries
Generex Biotechnology Corp, Key Competitors
Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Generex Biotechnology Corp, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

StageZero Life Sciences Ltd
Sernova Corp
Novo Nordisk AS
Novavax Inc
Merck & Co Inc
MedImmune, Inc.
GlaxoSmithKline Plc
Eli Lilly and Co
Aptose Biosciences Inc
Apotex Inc
Ambrilia Biopharma Inc